HIV controllers: a multifactorial phenotype of spontaneous viral suppression - PubMed
Review
HIV controllers: a multifactorial phenotype of spontaneous viral suppression
Jacques Thèze et al. Clin Immunol. 2011 Oct.
Abstract
A small minority of HIV-infected individuals, known as HIV controllers, is able to exert long-term control over HIV replication in the absence of treatment. Increasing evidence suggests that the adaptive immune system plays a critical role in this control but also that a combination of several host and/or viral factors, rather than a single cause, leads to this rare phenotype. Here, we review recent advances in the study of these remarkable individuals. We summarize the epidemiology and clinical characteristics of HIV controllers, and subsequently describe contributing roles of host genetic factors, innate and adaptive immune responses, and viral factors to this phenotype. We emphasize distinctive characteristics of HIV-specific CD4 T cell responses and of CD4 T cell subpopulations that are frequently found in HIV controllers. We discuss major controversies in the field and the relevance of the study of HIV controllers for the development of novel therapeutic strategies and vaccines.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Ferre AL, Hunt PW, McConnell DH, Morris MM, Garcia JC, Pollard RB, Yee HF Jr, Martin JN, Deeks SG, Shacklett BL. Ferre AL, et al. J Virol. 2010 Nov;84(21):11020-9. doi: 10.1128/JVI.00980-10. Epub 2010 Aug 18. J Virol. 2010. PMID: 20719952 Free PMC article.
-
Mucosal immunity in HIV controllers: the right place at the right time.
Shacklett BL, Ferre AL. Shacklett BL, et al. Curr Opin HIV AIDS. 2011 May;6(3):202-7. doi: 10.1097/COH.0b013e3283453e2b. Curr Opin HIV AIDS. 2011. PMID: 21399497 Free PMC article. Review.
-
Gonzalez SM, Taborda NA, Correa LA, Castro GA, Hernandez JC, Montoya CJ, Rugeles MT. Gonzalez SM, et al. Immunol Res. 2016 Jun;64(3):765-74. doi: 10.1007/s12026-015-8775-5. Immunol Res. 2016. PMID: 26724942
-
Ferre AL, Lemongello D, Hunt PW, Morris MM, Garcia JC, Pollard RB, Yee HF Jr, Martin JN, Deeks SG, Shacklett BL. Ferre AL, et al. J Virol. 2010 Oct;84(19):10354-65. doi: 10.1128/JVI.00803-10. Epub 2010 Jul 28. J Virol. 2010. PMID: 20668079 Free PMC article.
-
Th17 cells and regulatory T cells in elite control over HIV and SIV.
Hartigan-O'Connor DJ, Hirao LA, McCune JM, Dandekar S. Hartigan-O'Connor DJ, et al. Curr Opin HIV AIDS. 2011 May;6(3):221-7. doi: 10.1097/COH.0b013e32834577b3. Curr Opin HIV AIDS. 2011. PMID: 21399494 Free PMC article. Review.
Cited by
-
Revealing the role of CD4(+) T cells in viral immunity.
Sant AJ, McMichael A. Sant AJ, et al. J Exp Med. 2012 Jul 30;209(8):1391-5. doi: 10.1084/jem.20121517. J Exp Med. 2012. PMID: 22851641 Free PMC article. Review.
-
Overcoming the Constraints of Anti-HIV/CD89 Bispecific Antibodies That Limit Viral Inhibition.
Yu X, Duval M, Gawron M, Posner MR, Cavacini LA. Yu X, et al. J Immunol Res. 2016;2016:9425172. doi: 10.1155/2016/9425172. Epub 2016 Jun 22. J Immunol Res. 2016. PMID: 27419146 Free PMC article.
-
Immune Correlates of Natural HIV Elite Control and Simultaneous HCV Clearance-Supercontrollers.
Dominguez-Molina B, Ferrando-Martinez S, Tarancon-Diez L, Hernandez-Quero J, Genebat M, Vidal F, Muñoz-Fernandez MA, Leal M, Koup R, Ruiz-Mateos E. Dominguez-Molina B, et al. Front Immunol. 2018 Dec 10;9:2897. doi: 10.3389/fimmu.2018.02897. eCollection 2018. Front Immunol. 2018. PMID: 30619267 Free PMC article.
-
Elevated glycolysis imparts functional ability to CD8+ T cells in HIV infection.
Rahman AN, Liu J, Mujib S, Kidane S, Ali A, Szep S, Han C, Bonner P, Parsons M, Benko E, Kovacs C, Yue FY, Ostrowski M. Rahman AN, et al. Life Sci Alliance. 2021 Sep 21;4(11):e202101081. doi: 10.26508/lsa.202101081. Print 2021 Nov. Life Sci Alliance. 2021. PMID: 34548381 Free PMC article.
-
Nabi R, Moldoveanu Z, Wei Q, Golub ET, Durkin HG, Greenblatt RM, Herold BC, Nowicki MJ, Kassaye S, Cho MW, Pinter A, Landay AL, Mestecky J, Kozlowski PA. Nabi R, et al. PLoS One. 2017 Jul 3;12(7):e0180245. doi: 10.1371/journal.pone.0180245. eCollection 2017. PLoS One. 2017. PMID: 28671952 Free PMC article.
References
-
- Deeks SG, Walker BD. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity. 2007;27:406–416. - PubMed
-
- Lambotte O, Boufassa F, Madec Y, Nguyen A, Goujard C, Meyer L, Rouzioux C, Venet A, Delfraissy JF. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin Infect Dis. 2005;41:1053–1056. - PubMed
-
- Okulicz JF, Marconi VC, Landrum ML, Wegner S, Weintrob A, Ganesan A, Hale B, Crum-Cianflone N, Delmar J, Barthel V, Quinnan G, Agan BK, Dolan MJ. Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study. J Infect Dis. 2009;200:1714–1723. - PubMed
-
- Hatano H, Delwart EL, Norris PJ, Lee TH, Dunn-Williams J, Hunt PW, Hoh R, Stramer SL, Linnen JM, McCune JM, Martin JN, Busch MP, Deeks SG. Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy. J Virol. 2009;83:329–335. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials